Maravai Lifesciences Holdings, Inc.
(NASDAQ : MRVI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 2.24%241.277.5%$432.23m
PAGSPagSeguro Digital Ltd. -3.56%37.710.0%$190.55m
BTBTBit Digital, Inc. -7.55%10.170.0%$166.36m
EFXEquifax, Inc. 4.99%268.222.0%$163.73m
CRLCharles River Laboratories International, Inc. 0.84%420.714.5%$143.93m
FLTFLEETCOR Technologies, Inc. 0.06%277.503.6%$116.96m
CPRTCopart, Inc. 0.28%152.274.4%$111.61m
CHGGChegg, Inc. -2.49%59.8913.1%$106.55m
TASKTaskUs, Inc. -3.71%59.180.0%$83.39m
FOURShift4 Payments, Inc. 0.05%76.860.0%$80.25m
MRVIMaravai Lifesciences Holdings, Inc. -0.55%42.000.0%$71.00m
BAHBooz Allen Hamilton Holding Corp. -0.19%82.952.1%$70.48m
PPDPPD, Inc. -0.02%47.030.0%$65.97m
CLVTClarivate Plc -1.03%22.200.0%$64.80m
TALTAL Education Group -1.53%4.820.7%$57.27m

Company Profile

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics,and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.